论文部分内容阅读
近年来,国内外研究资料结果表明高脂血症是动脉粥样硬化(AS)或冠心病的主要危险因素,内膜中脂质沉积是动脉粥样硬化发生的始动环节,因而处理高脂血症是防治本病的重要措施。袁家玑教授经验方一“冠心通络舒郁丸”(以下称本方),经我院多年临床应用,疗效显著。我们选用本方,通过测定血清总胆固醇(TC)、甘油三脂(TG)、高密度脂蛋白胆固醇(HDL—Ch)、脂蛋白电泳,观察本方对动脉粥样硬化形成的影响。
In recent years, research results at home and abroad have shown that hyperlipidemia is a major risk factor for atherosclerosis (AS) or coronary heart disease. Lipid deposition in the intima is the starting point for the development of atherosclerosis, thus dealing with hyperlipidemia. Hyperlipemia is an important measure to prevent and treat this disease. Prof. Yuan Jiaxuan’s experience in the treatment of “Guanxin Tongluo Shuyu Pill” (hereinafter referred to as “the party”) has been clinically applied in our hospital for many years. We used this prescription to determine the effect of this prescription on atherosclerosis by measuring serum total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-Ch), and lipoprotein electrophoresis.